These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38518893

  • 21. Predictive factors for osteoradionecrosis of the jaws: A retrospective study.
    Sathasivam HP, Davies GR, Boyd NM.
    Head Neck; 2018 Jan; 40(1):46-54. PubMed ID: 29149496
    [Abstract] [Full Text] [Related]

  • 22. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
    Hong RL, Hsiao CF, Ting LL, Ko JY, Wang CW, Chang JTC, Lou PJ, Wang HM, Tsai MH, Lai SC, Liu TW.
    Ann Oncol; 2018 Sep 01; 29(9):1972-1979. PubMed ID: 30016391
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study.
    Chen TM, Lin KC, Yuan KS, Chang CL, Chow JM, Wu SY.
    Radiother Oncol; 2018 Oct 01; 129(1):23-29. PubMed ID: 29277447
    [Abstract] [Full Text] [Related]

  • 26. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q, Lu L, Wang X, Lin Y, Chen Y, Chen H, Chen S, Lin S, Zhang Y, Zheng P, Chen X.
    Am J Otolaryngol; 2022 Oct 01; 43(1):103193. PubMed ID: 34509080
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma.
    Zhang J, Peng H, Li WF, Zhang Y, Liu LZ, Tian L, Lin AH, Sun Y, Ma J.
    BMC Cancer; 2018 Dec 19; 18(1):1276. PubMed ID: 30567511
    [Abstract] [Full Text] [Related]

  • 30. Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma.
    Chen R, Lu Y, Zhang Y, He R, Tang F, Yuan W, Li Y, Zhang X.
    Medicine (Baltimore); 2021 Oct 22; 100(42):e27475. PubMed ID: 34678878
    [Abstract] [Full Text] [Related]

  • 31. Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients.
    Chen YP, Chen C, Mai ZY, Gao J, Shen LJ, Zhao BC, Chen MK, Chen G, Yan F, Huang TY, Xia YF.
    Oncol Lett; 2015 Mar 22; 9(3):1458-1466. PubMed ID: 25663931
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).
    Dong D, Zhang F, Zhong LZ, Fang MJ, Huang CL, Yao JJ, Sun Y, Tian J, Ma J, Tang LL.
    BMC Med; 2019 Oct 23; 17(1):190. PubMed ID: 31640711
    [Abstract] [Full Text] [Related]

  • 34. Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.
    Yang Z, Cai Z, Cai Q, Hong Y, Zhang C, Huang K, Lin Z, Li M.
    Cancer Med; 2021 Jun 23; 10(12):3886-3895. PubMed ID: 33955190
    [Abstract] [Full Text] [Related]

  • 35. [The past, present and future of diagnosis and treatment of osteoradionecrosis of the jaws].
    He Y.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 May 09; 56(5):410-414. PubMed ID: 33904273
    [Abstract] [Full Text] [Related]

  • 36. MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.
    Shen H, Yin J, Niu R, Lian Y, Huang Y, Tu C, Liu D, Wang X, Lan X, Yuan X, Zhang J.
    Radiother Oncol; 2022 Jun 09; 171():107-113. PubMed ID: 35461950
    [Abstract] [Full Text] [Related]

  • 37. Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial.
    Yan P, Yin H, Guo W, Sun X, Li F, Huang S, Bian X, Wang F, Zhang F, Wang B, Zhou H, Zhou C, Yin L, Jiang X, Jiang N, Wu J, Liu J, Song D, He X.
    Cancer Med; 2020 Sep 09; 9(17):6166-6172. PubMed ID: 32657029
    [Abstract] [Full Text] [Related]

  • 38. Induction Chemotherapy plus Concurrent Chemoradiotherapy vs Concurrent Chemoradiotherapy in Elderly Patients with Advanced Nasopharyngeal Carcinoma.
    Wang C, Tang X, Wang J, Song J, Xu Y.
    Otolaryngol Head Neck Surg; 2017 Aug 09; 157(2):233-238. PubMed ID: 28418781
    [Abstract] [Full Text] [Related]

  • 39. Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
    Mané M, Benkhaled S, Dragan T, Paesmans M, Beauvois S, Lalami Y, Szturz P, Gaye PM, Vermorken JB, Van Gestel D.
    Oncologist; 2021 Jan 09; 26(1):e130-e141. PubMed ID: 32924198
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers.
    Tao HY, He F, Shi QY, Liu R, Wang ZL, Du KP, Li JF, Liu H, Lu ZQ, Zhang JJ, Bai YH.
    Cancer Med; 2023 Mar 09; 12(6):6811-6824. PubMed ID: 36420689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.